Wills Robert James 4
4 · Oncternal Therapeutics, Inc. · Filed Apr 10, 2024
Insider Transaction Report
Form 4
Wills Robert James
DirectorExecutive Chairman
Transactions
- Purchase
Common Stock
2024-04-08$8.96/sh+3,086$27,655→ 10,000 total
Footnotes (2)
- [F1]The common stock purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, but the reporting person previously paid the Issuer the full amount of the profit realized in connection with the short swing transaction. No further amounts are required to be disgorged.
- [F2]The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.76 to $9.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.